23
Last reporting period 30 Jun, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.216
Exchange
XHKG - Hong Kong Exchange
0.93 B
Last period Cash and equivalents ,CNY
475%
Cash and equivalents has increased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Dawnrays Pharmaceutical
Company Analysis
2348.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2348.HK financial analysis by Eyestock methodology
Valuation
2348.HK valuation using historical relative method
Statements
2348.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2348.HK dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Dawnrays Pharmaceutical`s Cash and equivalents for the period ended 2023-06-30 are 0.93 B CNY
